Overcoming Downstream Challenges in the Reduction of Key Process- & Product-related Impurities of an Antibody Drug Conjugate (ADC)

Time: 12:00 pm
day: day 1 track 3 am

Details:

  • Identify critical and difficult to
    remove impurities
  • Evaluate development strategies
    and results
  • Discuss transfer, scale-up, and
    GMP manufacturing results